BlackRock Investment Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$406K Hold
159,176
﹤0.01% 3083
2016
Q3
$492K Sell
159,176
-729
-0.5% -$2.25K ﹤0.01% 3038
2016
Q2
$513K Buy
159,905
+10,473
+7% +$33.6K ﹤0.01% 3045
2016
Q1
$463K Buy
149,432
+939
+0.6% +$2.91K ﹤0.01% 2922
2015
Q4
$595K Buy
148,493
+187
+0.1% +$749 ﹤0.01% 2923
2015
Q3
$679K Sell
148,306
-1,007
-0.7% -$4.61K ﹤0.01% 2877
2015
Q2
$775K Buy
149,313
+39,890
+36% +$207K ﹤0.01% 2937
2015
Q1
$685K Buy
109,423
+482
+0.4% +$3.02K ﹤0.01% 2783
2014
Q4
$685K Sell
108,941
-1,058
-1% -$6.65K ﹤0.01% 2811
2014
Q3
$669K Buy
109,999
+2,404
+2% +$14.6K ﹤0.01% 2790
2014
Q2
$709K Buy
107,595
+23,363
+28% +$154K ﹤0.01% 2831
2014
Q1
$2.01M Sell
84,232
-365
-0.4% -$8.69K ﹤0.01% 2029
2013
Q4
$903K Sell
84,597
-1,940
-2% -$20.7K ﹤0.01% 2560
2013
Q3
$1.15M Buy
86,537
+5,581
+7% +$74.4K ﹤0.01% 2334
2013
Q2
$1.06M Buy
+80,956
New +$1.06M ﹤0.01% 2311